3
2
1

Shandong Yinfeng Institute of Life Sciences has joined the International Consultation Center and Shandong Provincial Clinical Research Center for Brain and Neurological Diseases

Release time:

2020-11-24

 Jinan has warm and sunny weather in winter. On November 20-21, 2020, the Shandong Association of Pain Medicine, Shandong Association of Geriatrics and Geriatrics, and Shandong Association of Geriatrics jointly held an academic annual conference in Beautiful Spring City. Shandong Yinfeng Institute of Life Sciences (research unit of our foundation) was invited to attend this conference.
Yu Fenggang, the business director of Shandong Yinfeng Life Science Research Institute, delivered a keynote speech titled "Neural stem cells: The advantages and challenges" at the conference. He had in-depth exchanges with experts, scholars, and industry practitioners on cutting-edge hot topics such as neural stem cell research and application, cell biotechnology, etc., opening up an exciting entry point for achieving better biomedical research. Under the strategic layout of Yinfeng Biotechnology Group, Yinfeng Life Sciences Research Institute is committed to the research of new technologies and products in the field of life sciences, such as stem cell technology, cell therapy research, genomics, human cells, tissues, and organ low-temperature preservation and recovery, and promotes the transformation of basic research into clinical and public health prevention and control applications. This attendance and on-site exchange of innovative technologies and research achievements in (stem) cell research and development with everyone, Has attracted the attention of numerous biomedical systems and professionals.

银丰生命

  As a comprehensive research unit of the entire industry chain research system for cell tissue resource storage, technology research, and product transformation, Yinfeng Life Sciences Research Institute has joined the International Consultation Center and the Shandong Provincial Clinical Research Center for Brain and Neurological Diseases, laying the foundation for the next joint international multicenter clinical research on neural stem cell therapy for neurological injury. Our hospital is willing to work together with everyone with more enthusiasm and effort to promote new development in the biomedical industry, solve more problems, and ensure human life and health.

Latest developments

"10th China Contemporary Thanatology Symposium in Macao: Yinfeng Promotes Life Education Through Technology"

Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.

The World’s First Ovarian Tissue Dual-Activation Technology Selected into the 2025 "Shandong Outstanding Achievements Report" Project

According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).

Focus on Frigid Zone Medicine: Yinfeng Low - Temperature Medical Team Publishes an Important Review on Cryopreservation

Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.

Yinfeng Institute’s Ovarian Tissue Cryopreservation Technology Wins Shandong Refrigeration and Air Conditioning Science and Technology Award

Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.

Developing Countries Officials Training Workshop Visits Yinfeng Biological Group to Explore Frontiers of Life Sciences

On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.